About Xylo Technologies Ltd. (XYLO) — Dividend Analysis 2026
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.
Is XYLO a good dividend investment in 2026?
XYLO offers a 39.45% forward yield with a 50% payout ratio. Strand Safety Score: 15/100 (Critical Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
XYLO DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your XYLO portfolio grows to $14.84M vs $10.28M without reinvestment. This is the compound interest effect in action.
XYLO dividend growth history & forecast
XYLO has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 39.45%.
Company generates negative FCF ($-2M) — borrowing to pay dividends
Debt Leverage0.0× Debt/EBITDA
0 / 30 pts
0/30
Company not generating EBITDA — debt servicing risk is elevated
Earnings Momentum-0.0B → -0.0B → -0.0B
15 / 30 pts
15/30
Net income grew in the latest year — positive but trend is unconfirmed
OVERALL ASSESSMENT
High risk of dividend cut — weak fundamentals across multiple factors.
STRAND SCORE
15
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 XYLO Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold XYLO.
Gross yield
39.45%
Tax rate
15.00%
After-tax yield
33.53%
Real yield (−CPI)
30.73%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
39.45%
36.65%
$3,945 / yr
🇺🇸 US Taxable (15%) ✓
15%
33.53%
30.73%
$3,353 / yr
🇺🇸 US Taxable (20%)
20%
31.56%
28.76%
$3,156 / yr
🇬🇧 UK ISA
0%
39.45%
36.65%
$3,945 / yr
🇬🇧 UK Taxable
8.75%
36.00%
33.20%
$3,600 / yr
🇨🇦 TFSA
0%
39.45%
36.65%
$3,945 / yr
🇨🇦 CA Taxable
25%
29.59%
26.79%
$2,959 / yr
🇦🇺 Super (pension)
15%
33.53%
30.73%
$3,353 / yr
🇦🇺 AU Taxable
30%
27.62%
24.82%
$2,762 / yr
🇩🇪 DE Taxable
26.375%
29.05%
26.25%
$2,905 / yr
🇫🇷 FR Taxable
30%
27.62%
24.82%
$2,762 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 XYLO Income Goal & Break-Even
Dividend Break-Even
3yr
Years for dividends to fully repay your XYLO investment of $5.07/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$43.4K
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$40.9K
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in XYLO for:
Shares needed
14,118
Capital required
$71,578
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 XYLO Dividend Payment Schedule
XYLO pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 XYLO vs Healthcare Benchmarks
How XYLO compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+36.65% vs sectorBetter
XYLO
39.45%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
XYLO
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
XYLO
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for XYLO sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ XYLO Insider Activity
No recent SEC filings reported in the last 90 days.
🔬
Financial Health Scores
Altman Z-Score
-3.77
🔴 Distress Zone — elevated dividend cut risk
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
3/9
🔴 Weak fundamentals — dividend safety concern
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the XYLO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →